British American Tobacco is selling flavored CBD vapes in the United Kingdom as it eyes new products beyond tobacco and nicotine.
But the parent company of Lucky Strike says it is not ready to enter the THC market yet.
The company’s Chief Marketing Officer, Kingsley Wheaton, told CNBC this week that CBD is an “exciting growth area for our business for the future.”
Last month the company launched a CBD vaping product called Vuse in England. Wheaton called the launch a testing and learning experience but did not disclose sales.
Wheaton said the tobacco company is holding off on THC inhalables because of limited market access.
“It’s a very different regulatory landscape as you go around the world, and many markets remain currently inaccessible for regulatory reasons,” he said.
British American Tobacco trades on the NYSE as BAT.
The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.